Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
89 studies found for:    Open Studies | "Osteosarcoma"
Show Display Options
RSS Create an RSS feed from your search for:
Open Studies | "Osteosarcoma"
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Recruiting ABCB1/P-glycoprotein Expression as Biologic Stratification Factor for Patients With Non Metastatic Osteosarcoma
Condition: Osteosarcoma
Interventions: Drug: Mifamurtide arm;   Other: 3 drugs arm
2 Recruiting Outpatient Administration of High Dose Methotrexate (HD MTX) in Patients With Osteosarcoma
Condition: Osteosarcoma
Intervention: Drug: High Dose Methotrexate
3 Recruiting Combination of External Beam Radiotherapy With 153Sm-EDTMP to Treat High Risk Osteosarcoma
Condition: Metastatic Osteosarcoma
Interventions: Drug: Sm-EDTMP;   Other: Autologous Stem Cell Infusion;   Radiation: External Beam Radiotherapy
4 Not yet recruiting Therapy Trial to Determine the Safety and Efficacy of Heavy Ion Radiotherapy in Patients With Osteosarcoma
Condition: Osteosarcoma
Intervention: Radiation: heavy ion radiotherapy (C12)
5 Recruiting Phase II Trial for the Treatment of Relapsed Osteosarcoma
Condition: OSTEOSARCOMA
Interventions: Drug: Gemcitabine and Docetaxel;   Drug: Ifosfamide
6 Recruiting Clinical Trial of Lithium Carbonate Combined With Neo-adjuvant Chemotherapy to Treat Osteosarcoma
Condition: Osteosarcoma
Interventions: Drug: Lithium Carbonate;   Drug: Placebo
7 Recruiting Investigation of [6R] 5,10-methylenetetrahydrofolate as Rescue Therapy for Osteosarcoma Patients Treated With HDMTX.
Condition: Osteosarcoma
Interventions: Drug: Leucovorin;   Drug: [6R] 5,10-methylenetetrahydrofolate
8 Recruiting Glembatumumab Vedotin in Treating Patients With Recurrent or Refractory Osteosarcoma
Condition: Recurrent Osteosarcoma
Interventions: Drug: Glembatumumab Vedotin;   Other: Laboratory Biomarker Analysis;   Other: Pharmacological Study
9 Recruiting Humanized Monoclonal Antibody 3F8 (Hu3F8) With Granulocyte-Macrophage Colony Stimulating Factor (GM-CSF) in the Treatment of Recurrent Osteosarcoma
Condition: Recurrent Osteosarcoma
Interventions: Biological: humanized anti-GD2 antibody;   Drug: GM-CSF
10 Recruiting Apatinib for Advanced Osteosarcoma After Failure of Standard Multimodal Therapy
Conditions: Osteosarcoma;   Metastasis
Intervention: Drug: apatinib
11 Recruiting Chemotherapy Resistance in Osteogenic Sarcoma and Other Solid Tumors
Condition: Osteosarcoma
Intervention: Biological: Tissue Procurement
12 Recruiting Denosumab in Treating Patients With Recurrent or Refractory Osteosarcoma
Conditions: Childhood Osteosarcoma;   Metastatic Osteosarcoma;   Recurrent Osteosarcoma
Interventions: Biological: Denosumab;   Other: Laboratory Biomarker Analysis;   Other: Pharmacological Study
13 Recruiting Metronomic Chemotherapy in Patients With Advanced Solid Tumor With Bone Metastasis and Advanced Pretreated Osteosarcoma
Conditions: Solid Tumor;   Osteosarcoma
Intervention: Drug: Sirolimus combined with CP, MT and ZA
14 Recruiting Preventing Nephrotoxicity and Ototoxicity From Osteosarcoma Therapy
Conditions: Osteosarcoma;   Nephrotoxicity;   Ototoxicity
Interventions: Drug: Pantoprazole;   Drug: High-dose methotrexate infusion duration
15 Recruiting Prospective Clinical Trial Evaluating Metronomic Chemotherapy in Patients With High-grade, Operable, Non-metastatic Osteosarcoma of the Extremity
Condition: High Grade Osteosarcoma
Intervention: Drug: continuous oral cyclophosphamide and methotrexate
16 Recruiting Dinutuximab in Combination With Sargramostim in Treating Patients With Recurrent Osteosarcoma
Conditions: Metastatic Malignant Neoplasm in the Lung;   Metastatic Osteosarcoma;   Recurrent Osteosarcoma
Interventions: Biological: Dinutuximab;   Other: Laboratory Biomarker Analysis;   Other: Pharmacological Study;   Biological: Sargramostim
17 Recruiting Collecting and Storing Samples of Blood and Tumor Tissue From Patients With Osteosarcoma
Condition: Sarcoma
Intervention: Other: biologic sample preservation procedure
18 Recruiting Monocyte Phenotypic and Functional Differences
Condition: Osteosarcoma
Intervention: Biological: Blood draw
19 Recruiting Study of Lenvatinib in Children and Adolescents With Refractory or Relapsed Solid Malignancies and Young Adults With Osteosarcoma
Conditions: Tumors;   Solid Malignant Tumors;   Osteosarcoma;   Differentiated Thyroid Cancer (DTC)
Interventions: Drug: Lenvatinib;   Drug: Ifosfamide;   Drug: Etoposide
20 Recruiting SARC024: A Blanket Protocol to Study Oral Regorafenib in Patients With Refractory Liposarcoma, Osteogenic Sarcoma, and Ewing Sarcomas
Conditions: Liposarcoma;   Osteogenic Sarcoma;   Ewing/Ewing-like Sarcoma
Interventions: Drug: Regorafenib;   Drug: Placebo

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.